Tuesday, July 7, 2026
ADVT 
National

Raed Jaser, convicted in Via Rail terror plot, loses appeal

Darpan News Desk The Canadian Press, 12 Jun, 2024 10:29 AM
  • Raed Jaser, convicted in Via Rail terror plot, loses appeal

Ontario's highest court has upheld the conviction and life sentence of one of the two men found guilty of terrorism charges in a plot to derail a passenger train between Canada and the U.S.

Raed Jaser had challenged the outcome of the 2015 trial on several grounds, including that his case should have been severed from that of his co-accused, Chiheb Esseghaier – something he requested twice, unsuccessfully.

Esseghaier, who was self-represented, refused to meaningfully participate in the court proceedings related to the trial, saying he would only be judged by the Qur'an, and had several outbursts in court, including one where he spat at lawyers and threw a cup of water.

Jaser argued on appeal that the trial judge's refusal to grant him a separate trial compromised the fairness of the proceedings.

In a unanimous ruling released Wednesday, the Court of Appeal for Ontario said the trial judge made reasonable and legally correct decisions on the issue, and going ahead with a joint trial "did not result in an injustice."

"It must be emphasized that the trial judge was confronted with an uncommon severance scenario. The more common situation involves accused persons who are adverse in interest on factual or legal issues, whereas this was a case of a disruptive co-accused," the court wrote.

Having spent many hours talking to Esseghaier during the court process, the trial judge was in the best position to assess the situation as well as "the feasibility of the steps he took to preserve trial fairness," and deference to his discretion is important, it wrote.

"This was a long, complex, and unique trial. It would have been a challenge for any trial judge to maintain the fairness of the proceedings for all concerned – both the two accused and the community, represented by the prosecution," the court wrote. "The trial judge managed to maintain that balance."

Jaser also argued the trial judge erred in assessing Esseghaier's fitness for sentencing, and should instead have found Esseghaier unfit and declared a mistrial for both of them.

The issue arose months after the jury delivered its verdict but before sentencing, according to the court ruling. The lawyer appointed by the court to assist Esseghaier requested a psychiatric evaluation to help with sentencing, the document said.

The psychiatrist's report went beyond a psychiatric diagnosis and suggested Esseghaier was not fit to go through the proceedings, the ruling said. The judge then ordered a second assessment that contradicted the first on the matter of fitness, it said.

The judge accepted the second opinion and continued with the sentencing process, the document said.

At the time, the judge noted that no one, including Jaser's lawyers, had raised any concerns over Esseghaier's fitness before the first psychiatric report, it said. He also found there were a number of flaws in the first report, it said.

Even if he had found Esseghaier unfit, the likely outcome would have been a delay in sentencing, not a mistrial, the court said.

"Once a jury has returned its verdict, a mistrial can be declared in only highly restricted circumstances," the court wrote.

In challenging his sentence, Jaser argued the trial judge didn't take into account the role of an undercover FBI agent in fuelling the conspiracy. Without the agent's "active encouragement," he argued, it's likely the plan wouldn't have come together.

The appeal court said it couldn't accept that argument based on the judge's findings that the pair had already come up with a plan involving multiple terrorist acts by the time they were introduced to the agent.

"On this view of the evidence, nothing (the agent) did could possibly have mitigated the culpability of Mr. Jaser for having entered into an agreement to commit mass murder," the appeal court said.

This is the second time the Appeal Court has weighed in on Jaser and Esseghaier's case.

They were found guilty in 2015 on a total of eight terror-related charges between them. They were sentenced to life in prison with no chance of parole until 2023.

Jaser and Esseghaier were granted a new trial in 2019 after the Appeal Court found the jury that convicted them was improperly selected.

However, the Supreme Court of Canada later ruled the pair had received a fair trial despite the error, sending the case back to the provincial Appeal Court to hear their challenges on other grounds.

Esseghaier eventually gave up his appeal of his conviction, but Jaser proceeded with his and further sought leave to appeal his sentence. The appeal court gave him leave to appeal his sentence but ultimately rejected the challenge.

MORE National ARTICLES

Man dies in Hope shooting

Man dies in Hope shooting
The province's homicide investigation team has been called in after a man was fatally shot in Hope. R-C-M-P say they were called just before 3 a.m. on Sunday and found a 28-year-old man who had been shot and killed.

Man dies in Hope shooting

Ottawa 'shouldn't walk around with a stick' to enforce health deals: Holland

Ottawa 'shouldn't walk around with a stick' to enforce health deals: Holland
Newly appointed Health Minister Mark Holland says he doesn't want to go waving a stick around as he negotiates the final details of a health accord with provinces and territories, and it'll largely be up to Canadians to hold them accountable. All provinces except Quebec accepted the $198-billion deal in principle earlier this year and are expected to sign final agreements before the end of 2023.

Ottawa 'shouldn't walk around with a stick' to enforce health deals: Holland

PharmaCare covers medicine to treat rare diseases

PharmaCare covers medicine to treat rare diseases
The province says its PharmaCare program now covers medications used to treat rare diseases such as A-L-S. The Ministry of Health says the oral form of edaravone, which is used to treat A-L-S patients, will be added to the PharmaCare formulary as a limited-coverage benefit.

PharmaCare covers medicine to treat rare diseases

Shortage of diabetes and weight loss drug Ozempic expected in Canada: manufacturer

Shortage of diabetes and weight loss drug Ozempic expected in Canada: manufacturer
A shortage of diabetes drug Ozempic that is used off-label for weight loss is expected in Canada, the manufacturer says. Health Canada says intermittent shortages are expected from late August to early October.  

Shortage of diabetes and weight loss drug Ozempic expected in Canada: manufacturer

Feds could spur rental construction with tax incentives, financing: experts

Feds could spur rental construction with tax incentives, financing: experts
Strong demand for rentals and a shortage of homes are both contributing to soaring rental costs. And that's making it even more difficult for people to save money for down payment on a home. For most minimum-wage workers, affording these rents with their earnings is impossible. 

Feds could spur rental construction with tax incentives, financing: experts

Home prices in Canada continue to rise

Home prices in Canada continue to rise
Home prices in Canada continued to rise last month, the fourth consecutive monthly increase. Eight of the 11 markets in the composite index were up in July led by Halifax at 4.9 per cent, Vancouver at 3.9 per cent and Toronto at 3.5 per cent.

Home prices in Canada continue to rise